Tsai‐Shen Yang
- Hepatology top 0.5%
- Hepatocellular Carcinoma Treatment and Prognosis 4
- Liver physiology and pathology 2
- Oncology top 0.5%
- Colorectal Cancer Treatments and Studies 11
- Cancer Treatment and Pharmacology 8
-
- Gastric Cancer Management and Outcomes 7
-
- Genetic factors in colorectal cancer 2
- Cancer Research top 5%
-
- Cholangiocarcinoma and Gallbladder Cancer Studies 4
-
- Advanced Biosensing Techniques and Applications 1
- Co-authors
- Arié FigerStephen ClarkeLeonard B. SaltzFernando RiveraFélix CoutureWerner ScheithauerSheryl KoskiFlorin Sirzén
- Partner nations
- TaiwanUnited StatesSwitzerland
In The Last Decade
Tsai‐Shen Yang
19 papers receiving 3.6k citations
Hit Papers
Peers
Comparison fields: 5 of 91
- Hepatology 1.3k
- Oncology 2.8k
- Pulmonary and Respiratory Medicine 1.1k
- Pathology and Forensic Medicine 588
- Cancer Research 426
Countries citing papers authored by Tsai‐Shen Yang
This map shows the geographic impact of Tsai‐Shen Yang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Tsai‐Shen Yang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Tsai‐Shen Yang more than expected).
Fields of papers citing papers by Tsai‐Shen Yang
This network shows the impact of papers produced by Tsai‐Shen Yang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Tsai‐Shen Yang. The network helps show where Tsai‐Shen Yang may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Tsai‐Shen Yang, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2023 | 14 | |
| 2 | 2018 | 2 | |
| 3 | 2016 | 80 | |
| 4 | Randomized, Multicenter, Open-Label Study of Oxaliplatin Plus Fluorouracil/Leucovorin Versus Doxorubicin As Palliative Chemotherapy in Patients With Advanced Hepatocellular Carcinoma From Asiabreakdown → | 2013 | 366 |
| 5 | 2012 | 24 | |
| 6 | 2012 | 92 | |
| 7 | Bevacizumab in Combination With Oxaliplatin-Based Chemotherapy As First-Line Therapy in Metastatic Colorectal Cancer: A Randomized Phase III Studybreakdown → | 2008 | 2275 |
| 8 | Randomized Phase III Study of Capecitabine Plus Oxaliplatin Compared With Fluorouracil/Folinic Acid Plus Oxaliplatin As First-Line Therapy for Metastatic Colorectal Cancerbreakdown → | 2008 | 652 |
| 9 | 2004 | 4 | |
| 10 | 2004 | 106 | |
| 11 | 2004 | 1 | |
| 12 | 2003 | 13 | |
| 13 | 2003 | 1 | |
| 14 | 2001 | 7 | |
| 15 | 2000 | 13 | |
| 16 | The Groshong Peripheral Inserted Central (PIC) Catheter: Initial Experience with Ultrasound-guided Insertion | 1999 | 1 |
| 17 | 1999 | 5 | |
| 18 | 1999 | 10 | |
| 19 | 1994 | 10 |
About Tsai‐Shen Yang
Tsai‐Shen Yang is a scholar working on Oncology, Hepatology and Internal Medicine, having authored 19 papers that have together received 3.7k indexed citations. Recurring topics across this work include Colorectal Cancer Treatments and Studies (11 papers), Cancer Treatment and Pharmacology (8 papers), Gastric Cancer Management and Outcomes (7 papers), Cholangiocarcinoma and Gallbladder Cancer Studies (4 papers), Hepatocellular Carcinoma Treatment and Prognosis (4 papers), Liver physiology and pathology (2 papers), Genetic factors in colorectal cancer (2 papers) and Advanced Biosensing Techniques and Applications (1 paper). The work is most often cited by research in Hepatology (1.3k citations), Oncology (2.8k citations) and Pulmonary and Respiratory Medicine (1.1k citations). Tsai‐Shen Yang has collaborated with scholars based in Taiwan, United States and Switzerland. Frequent co-authors include Arié Figer, Stephen Clarke, Leonard B. Saltz, Fernando Rivera, Félix Couture, Werner Scheithauer, Sheryl Koski, Florin Sirzén, Mikhail Lichinitser and Eduardo Díaz‐Rubio. Their work appears in journals such as Journal of Clinical Oncology, Anti-Cancer Drugs, Cancer, Melanoma Research and Chemotherapy.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.